Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

GlaxoSmithKline and Anacor Pharmaceuticals exploit novel mechanism for treating tuberculosis

April 28, 2016

Sun Pharma and partners establish malaria elimination demonstration project

April 27, 2016

hVIVO and SEEK in joint venture investment to develop vaccines against influenza and flu

April 27, 2016

AnGes and VIDO-InterVac collaborate to develop Ebola polyclonal antibody therapy

April 27, 2016

First-in-human results show potential of Ad26.ZEBOV and MVA-BN Filo Ebola vaccines

April 27, 2016

FDA approves AbbVie's sNDA for Viekira Pak

April 26, 2016

Cocrystal Pharma begins phase Ia/Ib study of HCV drug candidate

April 26, 2016

BARDA supports continued development of NewLink's Ebola vaccine candidate

April 26, 2016

SIGA enrolls patients in final cohort of phase III trial of tecovirimat

April 26, 2016

hVIVO reports favorable initial data from phase IIa study of PrEP-001 in influenza

April 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...